Embla Medical hf. (OSSFF)
OTCMKTS · Delayed Price · Currency is USD
4.150
+0.070 (1.72%)
At close: Mar 21, 2025
Embla Medical Market Cap
Embla Medical has a market cap or net worth of $2.13 billion as of August 4, 2025. Its market cap has increased by 19.39% in one year.
Market Cap
2.13B
Enterprise Value
2.59B
Revenue
873.51M
Ranking
n/a
PE Ratio
29.07
Stock Price
$4.15
Market Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 444.74M to 2.13B, an increase of 378.13%. That is a compound annual growth rate of 10.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 2.13B | 0.53% |
| Dec 30, 2024 | 2.12B | 23.63% |
| Dec 29, 2023 | 1.71B | -15.52% |
| Dec 30, 2022 | 2.03B | -25.54% |
| Dec 30, 2021 | 2.72B | -19.43% |
| Dec 30, 2020 | 3.38B | 1.84% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |